We examine here several diseases that are associated with inappropriate activation of the
chemokine network. Detailed comment has been restricted to pathological states for which
there are compelling data either from clinical observations or animal models. These include
cardiovascular disease, allergic inflammatory disease, transplantation, neuroinflammation,
cancer and HIV-associated disease. Discussion focuses on therapeutic directions in which
the rapidly evolving chemokine field appears to be headed.